Paxton says he’s protecting women from toxic products. He opened an investigation after winning the nomination, and nothing has come of it.
The feminine-care investigation was announced in July 2026 with no lawsuit or findings since, and his Tylenol suit rests on an autism link medical groups dispute.
Paxton claims his office is defending Texas women’s health against toxic chemicals in feminine-care products.
Source: Attorney General press release announcing investigations of feminine-care and lip-product brands, July 27, 2026 · Office of the Texas Attorney GeneralWhat the record shows
Paxton’s office announced investigations of Tampax, Kotex and other brands in July 2026, two months after he won the Republican Senate nomination. No lawsuit, finding or enforcement action has been reported. 01 02
His 2025 suit accusing the maker of Tylenol of misleading pregnant women rests on an autism link that medical groups dispute, and a judge rejected his request to block a $400 million shareholder payout. 03 04
The record behind this
- Judge rejects Paxton’s bid to block a $400 million Kenvue payout
A Panola County judge denied the state’s request to stop the dividend payments while the case is pending.
- Paxton’s women’s-products probe, announced after his nomination, has produced no lawsuit or findings
KPRC reported that the announcement did not allege wrongdoing and that no enforcement action had been filed.
No further public response found
We found no public statement from Paxton or his campaign on the status or results of the feminine-care investigation beyond the July 2026 announcement. 01
Sources
- 01Attorney General Paxton protects Texas women by launching landmark investigations into popular women’s brands over toxic chemicalsOffice of the Texas Attorney General · July 27, 2026
- 02Texas AG Ken Paxton launches investigation into Tampax, Kotex and other women’s brands over alleged toxic chemicalsKPRC Click2Houston · July 27, 2026
- 03Texas Attorney General Ken Paxton files Tylenol lawsuit over autism claimsCBS News · Oct. 28, 2025
- 04Paxton fails to block Tylenol maker from paying shareholdersThe Texas Tribune · Nov. 6, 2025